Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Clobetasol 17 Propionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 14 USDMF, 13 CEP/COS, 4 JDMF, 13 EU WC, 17 KDMF, 16 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 99 FDA Orange Book, 45 Europe, 25 Canada, 1 Australia, 9 South Africa, 36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.025%, AEROSOL, FOAM;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, SHAMPOO;TOPICAL - 0.05%, AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 4 DKSH, 1 Faran Shimi Pharmaceutical, 8 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 9 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Clariant, 14 Corel Pharma Chem, 1 Finar, 9 Gangwal Chemicals, 3 Ideal Cures, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 40 Topical, 23 Solubilizers, 20 Controlled & Modified Release, 16 Thickeners and Stabilizers, 14 Emulsifying Agents, 13 Parenteral, 12 Surfactant & Foaming Agents, 11 Film Formers & Plasticizers, 7 Rheology Modifiers, 6 Co-Processed Excipients, 6 Granulation, 5 Direct Compression, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Fillers, Diluents & Binders, 4 API Stability Enhancers, 4 Taste Masking, 3 Lubricants & Glidants, 2 Coloring Agents, 1 Chewable & Orodispersible Aids, 1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

87 News #PharmaBuzz

87 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 54 Regulatory FDF Prices

MARKET PLACE

21 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Symbiotec Pharmalab	India	M/s Symbiotec Pharmalab Pvt ltd	WC-0161A	Clobetasol Propionate USP/EP	2022-06-30	2025-07-02	385/2, Gram Pigdamber, Rau , Indore-453331, Madhya Pradesh, India
04/06/2025	Coral Drugs Private Limited	India	M/s Coral Drugs Pvt Ltd	WC-0009n	Clobetasol Propionate BP/USP/IP	2022-09-16	2025-07-05	Plot No. 55, 56 & 57, HSIIDC Industrial Estate, Murthal, Sonipat-131 029, Haryana India

Clobetasol 17 Propionate

Clobetasol 17 Propionate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

72 API Suppliers

14 USDMF

13 CEP/COS

4 JDMF

13 EU WC

17 KDMF

16 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers

99 FDA Orange Book

45 Europe

25 Canada

1 Australia

9 South Africa

36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.025%

AEROSOL, FOAM;TOPICAL - 0.05%

LOTION;TOPICAL - 0.05%

LOTION;TOPICAL - 0.05%

SHAMPOO;TOPICAL - 0.05%

AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

4 DKSH

1 Faran Shimi Pharmaceutical

8 Nanjing Well Pharmaceutical

1 ACG Worldwide

9 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

1 Clariant

14 Corel Pharma Chem

1 Finar

9 Gangwal Chemicals

3 Ideal Cures

17 Kerry

3 Kima Chemical

6 Lonza Capsugel

5 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

1 Novo Excipients

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 The Dow Chemical Company

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives

40 Topical

23 Solubilizers

20 Controlled & Modified Release

16 Thickeners and Stabilizers

14 Emulsifying Agents

13 Parenteral

12 Surfactant & Foaming Agents

11 Film Formers & Plasticizers

7 Rheology Modifiers

6 Co-Processed Excipients

6 Granulation

5 Direct Compression

5 Empty Capsules

4 Vegetarian Capsules

4 Fillers, Diluents & Binders

CREAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons